GeneDx Holdings (WGS) EV to EBIT (2020 - 2026)

GeneDx Holdings (WGS) has reported EV to EBIT for 7 consecutive years, with 109.62 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBIT fell 139.05% year-over-year to 109.62 in Q2 2026; TTM through Jun 2026 was 20.71, a 104.47% decrease from a year earlier, with the FY2025 full-year figure at 277.77, down 220.44% from the prior year.
• EV to EBIT was 109.62 for Q2 2026 at GeneDx Holdings, down from 30.18 in the prior quarter.
• Over five years, EV to EBIT peaked at 280.75 in Q2 2025 and troughed at 909.72 in Q3 2025.
• A 5-year average of 101.33 and a median of 17.15 in 2022 frame the typical range for EV to EBIT.
• The widest YoY moves for EV to EBIT: up 9880.92% in 2024, down 92184.15% in 2024.
• Over 5 years, EV to EBIT stood at 1.4 in 2022, then jumped by 263.64% to 2.29 in 2023, then jumped by 9880.92% to 228.5 in 2024, then slumped by 211.67% to 255.17 in 2025, then surged by 57.04% to 109.62 in 2026.
• The last three EV to EBIT figures came in at 109.62 (Q2 2026), 30.18 (Q1 2026), and 255.17 (Q4 2025), per Business Quant data.